This protocol presents techniques to laparoscopically excise ovarian endometrioma, to perform adhesiolysis with sparing electrosurgical application, and to employ intraoperative chromopertubation to assess for genital tract patency. This systematic approach will facilitate optimal endometriosis management, guide concomitant adnexal surgeries, and enhance post-surgical fertility outcomes.
Surgical management of ovarian endometrioma in patients desiring fertility is complicated by the need to balance maximal resection of disease with efforts to spare normal ovarian cortex. Optimization of tubal anatomy is another frequent consideration. Fertility-sparing laparoscopic techniques at the time of cystectomy for ovarian endometrioma seek to limit iatrogenic surgical damage to the ovarian cortex and strategically assess and respond to genital tract patency. Surgical candidates frequently desire relief from endometriosis-associated pain while also seeking to optimize spontaneous or assisted conception rates. Operative benefits include potential for surgical and histopathologic diagnosis of endometriosis, evaluation of genital tract patency, and treatment of visualized lesions. Resection of ovarian endometrioma nonetheless poses significant risks, including surgical injury, blood loss, post-surgical decline in ovarian reserve and post-operative inflammation with adhesion formation, both of which may impair folliculogenesis.
We present the case of a 32-year-old woman with known endometriosis and continued pain refractory to medical management who opted for surgical management of her disease tailored toward optimizing her chances at future conception. Using this case as an example, we describe techniques and considerations for diagnostic laparoscopy, adhesiolysis, ovarian cystectomy, chromopertubation, and salpingectomy with a focus on maintaining a fertility-preserving approach.
Endometriosis is a chronic inflammatory condition defined by ectopic endometrial tissue1. Patients with endometriosis commonly present with pain-related complaints and organ dysfunction related to the site of ectopic implantation, which may be anywhere in the body though is typically within the pelvis2,3. Ovarian endometrioma, in which a cyst of endometriosis forms within the ovary, contributes to subfertility by multiple means, including depletion of the ovarian follicle pool, promoting an inflammatory environment, progesterone resistance, and impaired ovum release and capture4. Affected patients frequently have diminished ovarian reserve upon presentation, and the follicle pool is further depleted following surgery5,6. Cyclic bleeding in sites with ectopic endometrial tissue leads to inflammation and significant adhesions, which may impair ovum pick-up and transport, fertilization, and embryo passage7,8,9. The abnormal inflammatory environment may also impair folliculogenesis and early embryonic development10,11.
At a practical surgical level, the resultant adhesions frequently obliterate normally avascular surgical planes, placing patients at elevated risk of prolonged operative times, blood loss, and surgical injury. Surgical management of patients desiring future fertility presents additional challenges, most notably risk of iatrogenic damage to the tubes and ovaries, compromising tubal patency or ovarian reserve12,13,14. However, surgical resection of endometriosis also presents a unique opportunity to potentially diagnose, evaluate, and treat identified lesions, including optimizing fertility15.
We detail our approach to the treatment of ovarian endometriomas in patients desiring future fertility. We strongly favor a laparoscopic approach over laparotomy for enhanced post-operative results, including less pain, shorter hospital stay, and quicker recovery16. This protocol prioritizes excision of ovarian endometrioma over drainage and ablation as it provides a more favorable outcome with respect to cyst recurrence, pain recurrence, and spontaneous pregnancies17,18,19,20. Additionally, it allows for the specimen retrieval for histology. We excise ovarian endometrioma via a stripping technique with limited electrosurgical energy application. Nonetheless, many specialized tools have been described for the management of ovarian endometrioma and multiple acceptable surgical approaches exist for patients desiring future fertility. Regardless of any specific technique employed, the considerations and surgical principles described in this protocol are applicable to all patients with endometriosis desiring fertility-optimizing surgery.
The protocol described below was employed for the care of a 32-year-old woman with chronic pelvic pain and histologically proven endometriosis identified during a prior laparoscopy, during which endometriosis was incompletely resected. She endorsed pain refractory to the first-line medical management and was interested in future fertility, although had not actively attempted spontaneous conception. She was deemed a candidate for minimally invasive surgical resection and underwent an exam under anesthesia, diagnostic laparoscopy, lysis of adhesions, ovarian cystectomy, chromopertubation, and salpingectomy. Her surgery and recovery were uncomplicated.
The patient described provided written informed consent for the use and publication of medical data, operative video, and related images for educational and scientific purposes. The following protocol adheres to the human research ethics committee guidelines of Montefiore Medical Center and New York City Health and Hospitals Corporation.
Due to limitations of the available raw recording, not every step in the protocol could be fully documented in the video on this patient.
1. Preoperative evaluation
NOTE: Select patients who are candidates for a minimally invasive surgical resection. Preoperative evaluation is important to create a comprehensive surgical plan and facilitate a thorough informed consent discussion to delineate indications for, risks of, benefits and alternatives to surgical management.
2. Exam under anesthesia and diagnostic laparoscopy
NOTE: The preoperative evaluation and exam under anesthesia are crucial to safely entering the peritoneum and guide the diagnostic laparoscopy.
3. Lysis of adhesions
NOTE: This phase is critical for the exposure, restoration of neutral anatomical position, and subsequent enhancement of genital tract function. Ovarian adhesions may prevent follicular development and extrusion of a ruptured follicle with ovulation, while fimbrial adhesions may compromise sweeping of an ovum. Additionally, adequate adhesiolysis is crucial to assure tubal patency. Adhesions are created by inflammatory states, whether by prior surgeries, infection, or endometriosis. Adhesions interfere with adequate exposure, distort anatomy, and subsequently increase complication risk when handling tissue and attempting plane development. Due to distorted anatomical planes, major pelvic vessels and the ureter are frequently in close proximity to the sites of dissection. The surgeon must be prepared to perform retroperitoneal dissection and ureterolysis for safe identification of anatomy.
4. Chromopertubation
5. Address tubal pathology
NOTE: Features of abnormal salpinges include irregular contours from adhesions or contents of hydro-, hemato-, or pyosalpinx. Salpinges are also pathologic if chromopertubation fails to demonstrate patency following adequate adhesiolysis. Abnormal salpinges are associated with poor spontaneous pregnancy rates and risk for ectopic pregnancy. Additionally, retrograde flow of tubal contents may reduce implantation rates. Bilateral salpingectomy or occlusion will necessitate in vitro fertilization for future fertility and must be explicitly defined in the surgical plan. Consider salpingectomy for irreparable salpinges when access to salpinges and mesosalpinx is feasible. Proximal tubal ligation to occlude retrograde flow of dilated tubal contents into the endometrial cavity is an acceptable alternative. Proximally occluded tubes may be left in situ.
6. Ovarian endometrioma cystectomy
NOTE: Cystectomy offers the lowest rate of endometrioma recurrence and has been demonstrated to improve pain outcomes and spontaneous pregnancy outcomes; however, it also removes more normal ovarian tissue than ablation (e.g., with CO2 laser). Endometrioma cyst walls are usually adherent from fibrosis and vascular at their base. The surgeon must balance removal of normal ovarian parenchyma and hemostasis with preservation of normal ovarian tissue. Cystectomy should only be attempted if the patient will be expected to have adequate ovarian reserve following the cystectomy. Removal of endometrioma in patients desiring fertility is generally restricted to lesions >3 cm and only if removal improves accessibility of follicles or endometriosis-associated pain.
7. Address the remaining sites of endometriosis per surgical plan
NOTE: Endometriosis outside of the ovary or tubes may have limited impact on spontaneous conception rate, but excision may be particularly important for treating pain or dysfunctional symptoms. Resection of implants should be site-directed. Peritoneal sites of endometriosis as well as other deep infiltrative sites should be addressed at this point. Retroperitoneal dissection is often required. Consider the morbidity of such procedures and patient goals when determining the necessity of such steps.
8. Closure
Table 1 shows results of our patient example. Total operation time was 251 min from anesthetic induction to extubation, with an estimated blood loss of 200 mL. The recovery period was uncomplicated. As she desired future pregnancy remote from the time of surgery, she began oral contraceptives. Histopathological examination revealed a right hydrosalpinx with paratubal cyst, bilateral endometriomas (4.5 cm and 3.7 cm), and ovarian tissue.
The surgery utilized a combination of fertility-sparing and fertility-optimizing approaches to laparoscopic cystectomy for ovarian endometrioma. Endometriomas previously visualized on imaging such as ultrasound or MRI (Figure 1) were removed from the ovary. Abdominal trocar placement (Figure 2) enabled visualization of all key pelvic anatomical structures, with demonstrated independent mobility of the uterus, fallopian tubes and ovaries and separation of these structures from the bladder, rectum, and pelvic sidewalls at the conclusion of the surgery. Fallopian tubal patency was characterized (Figure 3). Tubal adhesions were lysed and damaged/irreparable tubes were removed once this was demonstrated.
Endometrioma excision was achieved with a minimum amount of additional healthy ovarian cortex excised (Figure 4) at the same time thanks to efficient use of the stripping technique (Figure 5). All structures were confirmed to be hemostatic at the end of the case. The ovary was comprehensively evaluated, and any bleeding was addressed using the least damaging intervention possible.
At the completion of the surgery, this patient with bilateral ovarian endometriomas and significant tubal disease was treated for her pain, optimized for spontaneous conception and positioned to pursue assisted reproduction with a minimal decline in ovarian reserve.
Figure 1: Pre-operative MRI imaging. Please click here to view a larger version of this figure.
Figure 2: Suggested abdominal port placement. Circles represent minimum three-port placement. Consider placing up to two additional ports as marked by the encircled x. U represents umbilicus and P represents Palmer's point. Please click here to view a larger version of this figure.
Figure 3: Chromopertubation. Please click here to view a larger version of this figure.
Figure 4: Exposing the endometrioma. The endometrioma (pale, translucent object) is exposed after making an incision over the thinnest area of the endometrioma surface. Additional blunt dissection with a probe and suction irrigator free the adherent ovarian cortex from the endometrioma. Please click here to view a larger version of this figure.
Figure 5: Efficient use of traction-counter traction forces. (A) Dissecting the endometrioma from the normal ovary. Two graspers are used to place downward traction on the endometrioma cyst wall. In parallel, graspers stabilize and elevate the ovary to facilitate dissection. (B) Placement of graspers in closer proximity to the dissection plane (arrowhead) would result in a more efficient dissection. Please click here to view a larger version of this figure.
Number | |
Operative timea (min) | 251 |
Estimated blood loss (mL) | 200 |
Length of stay (days) | 0 |
Post-operative complications | 0 |
aOperative time is the number of minutes between intubation and extubation. |
Table 1. Results of fertility-sparing surgical resection.
Patients with diagnosed endometriosis commonly report pain or implant-related organ dysfunction, including infertility. Up to 50% of patients with endometriosis meet criteria for infertility23. Ovarian reserve, measured via AMH levels, FSH levels around menses or an antral follicle count, is used to predict patient response to gonadotropin stimulation. Surgical management of endometrioma is known to decrease ovarian reserve23. However, ovarian reserve continues to decline in patients with endometriomas even with conservative management14. Management of women with endometrioma remains debated and shared-decision making is crucial. Many patients opt for surgical resection of their disease for a variety of indications, including improvement of pain and to optimize post-surgical fertility outcomes.
In infertile women with mild/moderate endometriosis (rASRM stage I/II classification21), surgeons should excise or ablate endometriosis lesions and perform adhesiolysis to improve pregnancy rates17. Although studies are limited, research suggests that removal of the endometrioma capsule can aid spontaneous and even facilitate assisted reproduction. Endometriomas have the potential to interfere with assisted reproduction as they may preclude development of an adequate cohort of antral follicles and may incur the risk of infection if the endometrioma were to rupture at the time of oocyte retrieval1. Professional societies and expert opinions support ovarian cystectomy for endometriomas above a certain size among symptomatic patients with significant pain symptoms (>4 cm), medically refractory pain (<4 cm), and those planning assisted reproductive conception (ART) with concern for poor antral follicle count or possible cyst rupture during oocyte retrieval (<4 cm)1,24. Additionally, resection of endometrioma is favored compared with drainage and ablation due to lower rates of recurrence of dysmenorrhea and dyspareunia post-operatively.
Nonetheless, in patients who only desire fertility and report no other symptoms, many can avoid surgery, as pregnancy is often possible through assisted reproduction. Conservative non-surgical management should particularly be considered for patients with diminished ovarian reserve who are planning assisted reproduction, as even a successful surgery may affect their potential to obtain adequate oocytes from ovarian stimulation. For patients with endometrioma desiring surgical management, gynecological surgeons are urged to create surgical plans to minimize iatrogenic damage to ovarian reserve and optimize post-surgical fertility outcomes.
One of the critical advantages of surgery is it provides the opportunity to evaluate and treat identified lesions which may hamper future fertility2. The amount of normal ovarian tissue removed together with the endometrioma is related to the experience of the operator and is decreased with experience25. Stripping technique is our preference for ovarian cystectomy as it limits the use of electrosurgery on healthy ovarian tissue and thereby reduces the potential for lateral thermal spread. Similarly, all efforts should be made to limit damage to the anastomotic ovarian blood supply. Intraoperative bleeding from the ovarian tissue following endometrioma excision is a common complication. This protocol outlines the use of sparing ultrasonic application and use of hemostatic agents. All ovarian and related vasculature tissue should be managed as conservatively as possible to preserve ovarian reserve. Although not detailed in this video, alternative hemostatic techniques, including use of plasma energy, laser vaporization, and suturing, should be considered over electrosurgery application whenever feasible.
Adhesions and inflammatory-related sequelae of endometriosis are particularly prone to damage the salpinges, but the decision to remove them is often individualized. If chromopertubation after maximum adhesiolysis demonstrates genital tract obstruction, spontaneous conception via the affected tube is unlikely and salpingectomy may reduce the risk of ectopic pregnancy. However, salpingectomy appears to have a small but detectable detrimental effect on ovarian response to controlled ovarian hyperstimulation26. The decision to remove affected salpinges is more clear-cut for treatment of hydrosalpinx or hematosalpinx, as reflux of this fluid into the endometrial cavity appears to directly compromise implantation and early pregnancy rates.
In conclusion, this protocol visually reviews techniques for ovarian cystectomy and highlights important surgical principles during dissection and excision of endometrioma to reduce loss of ovarian reserve. A fertility-preserving resection of ovarian endometrioma also includes restoration of normal anatomy through adhesiolysis, evaluation of tubal patency and excision of irreparable tissue and removal of extraovarian endometriosis.
The authors have nothing to disclose.
None.
Basic laparoscopy | |||
1L bag 0.9% NaCl solution | Suction irrigation, hemostasis, lysis of adhesions | ||
1-10% povidone-iodine | Sterile prep | ||
2% chlorhexidine gluconate in 70% isopropyl alcohol for skin | Sterile prep | ||
4% chlorhexidine gluconate | Sterile prep | ||
5mm laparoscopic trocar and sleeve x 3 | Covidien | ONB5STF | Diagnostic laparoscopy |
12mm laparoscopic trocar and sleeve | Covidien | ONB12STF | Diagnostic laparoscopy and larger size facilitates specimen retrieval bag |
CO2 insufflator | Stryker | 620-040-504 | Diagnostic laparoscopy |
CO2 insufflator tubing | Stryker | 620-030-201 | Diagnostic laparoscopy |
Electrosurgical generator | Covidien | VLFT10GEN | Diagnostic laparoscopy |
Foley kit and urometer bag | Bard | 153214 | Diagnostic laparoscopy |
Laparoscopic scope, 5mm 0 degree | Olympus | WA4KL500 | Diagnostic laparoscopy |
Laparoscopic scope, 5mm 30 degree | Olympus | WA4KL530 | Diagnostic laparoscopy |
Laparoscopic suction irrigation pool tip | Stryker | 250-070-406 | Suction irrigation, hemostasis, lysis of adhesions |
StrykeFlow II suction irrigator | Stryker | 250-070-500 | Suction irrigation, hemostasis, lysis of adhesions |
Suction tubing | Stryker | 250-070-403 | Suction irrigation, hemostasis, lysis of adhesions |
Suction/vacuum source | Suction irrigation, hemostasis, lysis of adhesions | ||
Cystectomy and Salpingectomy | |||
10mm tissue retrieval bag | Covidien | 173050G | Specimen retrieval bag to be used in 12mm laparoscopic trocar site |
Atraumatic laparoscopic bowel graspers | Stryker | 250-080-319 | Lysis of adhesions, cystectomy, salpingectomy |
Bipolar Cord | Stryker | 250-040-016 | Lysis of adhesions, cystectomy, salpingectomy |
Endopeanut laparoscopic retractor | Covidien | 173019 | Lysis of adhesions, cystectomy, salpingectomy |
Harmonic ACE +7 ultrasonic shears | Ethicon | HARH23 | Lysis of adhesions, cystectomy, salpingectomy |
Laparoscopic bipolar grasping forceps | Karl Storz | 38951 MD | Lysis of adhesions, cystectomy, salpingectomy |
Laparoscopic curved Metzenbaum scissors | Stryker | 250-080-267 | Lysis of adhesions, cystectomy, salpingectomy |
Ultrasonic generator unit | Ethicon | GEN11 | Lysis of adhesions, cystectomy, salpingectomy |
Vasopressin solution (20 units in 50 to 100cc of injectable saline) | Cystectomy | ||
Chromopertubation | |||
10mg methylene blue in 150mL 0.9% NaCl solution | Pigmented solution for chromopertubation | ||
ZUMI uterine manipulator/injector | Cooper Surgical | ZSI1151 | Chromopertubation, diagnostic laparoscopy, lysis of adhesions |
Hemostatic agents | |||
Arista absorbable hemostatic particles 3g | Bard Davol | SM0002-USA | Hemostatic agent |
Floseal gelatin thrombin matrix 5ml | Baxter | ADS201844 | Hemostatic agent |
10mm tissue retrieval bag | Covidien | 173050G | |
Arista absorbable hemostatic particles 3g | Bard Davol | SM0002-USA | Hemostatic agent |
Atraumatic laparoscopic bowel graspers | Stryker | 250-080-319 | |
Endopeanut laparoscopic retractor | Covidien | 173019 | |
Floseal gelatin thrombin matrix 5ml | Baxter | ADS201844 | Hemostatic agent |
Harmonic ACE +7 ultrasonic shears | Ethicon | HARH23 | |
Laparoscopic bipolar grasping forceps | Karl Storz | 38951 MD | |
Laparoscopic curved Metzenbaum scissors | Stryker | 250-080-267 | |
Methylene blue 10mg in 150mL 0.9% NaCl solution | For chromopertubation | ||
ZUMI uterine manipulator/injector | Cooper Surgical | ZSI1151 | For uterine manipulation and chromopertubation |